Shares Investor Evening (London)

Shares Investor Evening (London)

Wednesday 4 September 2019

Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UK’s fastest growing listed companies.

The event on Wednesday 4 September 2019 in London will include:

• An opportunity for you to talk directly with the directors and ask your questions about the companies’ core strengths and their short and long-term business strategy

• Meet fellow investors and share your investing experience

• Complimentary drinks and snacks

More about the companies presenting:

Allergy Therapeutics (AGY) is a pharmaceutical products company. It develops therapies for allergy based diseases, having its primary market in Germany.

Belvoir Lettings (BLV) is uniquely positioned within the property sector, benefiting from the agility of a franchise business model compared with the larger corporate players, whilst providing our networks with the Central Office systems and support, not available to the smaller independent agents.

Open Orphan (ORPH) a European-focussed, rare and orphan drug consulting services platform. The Company will target the fragmented orphan drug services market in Europe

+ more to be announced...

Who Should Attend

The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors. 

Evening timings

Registration and coffee
Nick Wykeman, CFO - Allergy Therapeutics (AGY)
Dorian Gonsalves, CEO - Belvoir Lettings (BLV)
Cathal Friel, CEO - Open Orphan (ORPH)
+ More to be announced
Drinks reception and canapés


Novotel Tower Bridge, London EC3N 2NR

Sponsored by

Featured Companies